Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Vutiglabridin - Glaceum

Next Previous
Drug Profile

Vutiglabridin - Glaceum

Alternative Names: HSG-4112

Latest Information Update: 04 Sep 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Glaceum
  • Class Antiparkinsonians; Antirheumatics; Eye disorder therapies; Hepatoprotectants; Obesity therapies; Phenols; Pyrans; Small molecules
  • Mechanism of Action Inflammation mediator inhibitors; Metabolism stimulants; Triglyceride modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Obesity; Osteoarthritis; Parkinson's disease
  • Phase I Age-related macular degeneration; Non-alcoholic fatty liver disease

Most Recent Events

  • 04 Sep 2025 Phase-I development is ongoing for Non-alcoholic-fatty liver disease in South Korea (Glaceum pipeline, September 2025)
  • 04 Sep 2025 Phase-I clinical trials in Age-related macular degeneration in South Korea (PO), prior to September 2025 (Glaceum pipeline, September 2025)
  • 19 Aug 2025 Phase-II clinical trials in Osteoarthritis in South Korea (PO) (NCT06845553)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top